Quoted: The idea of using azithromycin for COVID-19 was based on preliminary French research suggesting a benefit that later was found to be flawed, said Ann Misch, an assistant professor of infectious disease at the University of Wisconsin School of Medicine and Public Health.
Separately, laboratory research showed hydroxychloroquine and azithromycin reduced viral replication of cells infected by the virus, though not azithromycin alone. But, she said, “there’s a huge chasm between an effect in cell culture and in humans.”
She said there is no evidence azithromycin is effective against COVID-19.
“If people are using azithromycin, I am sorry to hear that,” she said.